188 related articles for article (PubMed ID: 38696276)
1. Mitochondria-Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes.
Li HM; Wang MM; Su Y; Fang HB; Su Z
ChemMedChem; 2024 May; ():e202400120. PubMed ID: 38696276
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-Targeting Anticancer Metal Complexes.
Erxleben A
Curr Med Chem; 2019; 26(4):694-728. PubMed ID: 29521200
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
4. Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
Leon IE; Cadavid-Vargas JF; Di Virgilio AL; Etcheverry SB
Curr Med Chem; 2017; 24(2):112-148. PubMed ID: 27554807
[TBL] [Abstract][Full Text] [Related]
5. Metallodrugs as Anticancer Chemotherapeutics and Diagnostic Agents: A Critical Patent Review (2010-2020).
Fotopoulou E; Titilas I; Ronconi L
Recent Pat Anticancer Drug Discov; 2022; 17(1):42-54. PubMed ID: 34493191
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Mitochondria-Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents.
Patra SA; Sahu G; Das S; Dinda R
ChemMedChem; 2023 Nov; 18(22):e202300397. PubMed ID: 37772783
[TBL] [Abstract][Full Text] [Related]
7. Metallodrugs: an approach against invasion and metastasis in cancer treatment.
González-Ballesteros MM; Mejía C; Ruiz-Azuara L
FEBS Open Bio; 2022 May; 12(5):880-899. PubMed ID: 35170871
[TBL] [Abstract][Full Text] [Related]
8. Micro(nano)-plastics exposure induced programmed cell death and corresponding influence factors.
Wu Q; Cao J; Liu X; Zhu X; Huang C; Wang X; Song Y
Sci Total Environ; 2024 Apr; 921():171230. PubMed ID: 38402958
[TBL] [Abstract][Full Text] [Related]
9. DNA-Targeted Metallodrugs: An Untapped Source of Artificial Gene Editing Technology.
Fantoni NZ; Brown T; Kellett A
Chembiochem; 2021 Jul; 22(13):2184-2205. PubMed ID: 33570813
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
11. Next-generation anticancer metallodrugs.
Komeda S; Casini A
Curr Top Med Chem; 2012; 12(3):219-35. PubMed ID: 22236158
[TBL] [Abstract][Full Text] [Related]
12. Important molecular mechanisms in ferroptosis.
Lai L; Tan M; Hu M; Yue X; Tao L; Zhai Y; Li Y
Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38668809
[TBL] [Abstract][Full Text] [Related]
13. Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis.
Wendlocha D; Kubina R; Krzykawski K; Mielczarek-Palacz A
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674891
[TBL] [Abstract][Full Text] [Related]
14. Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives.
Yadav M; Niveria K; Sen T; Roy I; Verma AK
Nanomedicine (Lond); 2021 May; 16(12):1049-1065. PubMed ID: 33970686
[TBL] [Abstract][Full Text] [Related]
15. Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy.
Liu J; Lai H; Xiong Z; Chen B; Chen T
Chem Commun (Camb); 2019 Aug; 55(67):9904-9914. PubMed ID: 31360938
[TBL] [Abstract][Full Text] [Related]
16. Using bio-orthogonally catalyzed lethality strategy to generate mitochondria-targeting anti-tumor metallodrugs
Xue X; Qian C; Tao Q; Dai Y; Lv M; Dong J; Su Z; Qian Y; Zhao J; Liu HK; Guo Z
Natl Sci Rev; 2021 Sep; 8(9):nwaa286. PubMed ID: 34691728
[TBL] [Abstract][Full Text] [Related]
17. A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies.
Adhikari S; Nath P; Das A; Datta A; Baildya N; Duttaroy AK; Pathak S
Biomed Pharmacother; 2024 Feb; 171():116211. PubMed ID: 38290253
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric silicon phthalocyanine based nanoparticle with spatiotemporally targeting of mitochondria for synergistic apoptosis-ferroptosis antitumor treatment.
Huang Y; Liu G; Zheng F; Chen J; Lin Y; Wang J; Huang Y; Peng Y
Colloids Surf B Biointerfaces; 2024 Jun; 238():113890. PubMed ID: 38608462
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells.
Wang FY; Tang XM; Wang X; Huang KB; Feng HW; Chen ZF; Liu YN; Liang H
Eur J Med Chem; 2018 Jul; 155():639-650. PubMed ID: 29935437
[TBL] [Abstract][Full Text] [Related]
20. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
